P40 phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3631-3640

  Conway, Kara L ^a,b   Goel, Gautam ^a,b   Sokol, Harry ^a,c   Manocha, Monika ^a,d   Mizoguchi, Emiko ^a   Terhorst, Cox ^a,d   Bhan, Atul K ^a   Gardet, Agnès ^a,b   Xavier, Ramnik J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c SORBONNE UNIVERSITÉ   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CHEMOKINE RECEPTOR CCR1; DEXTRAN SULFATE; FUCOSYLTRANSFERASE; PROTEIN P40; PROTEIN P40 PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIALYLTRANSFERASE; UNCLASSIFIED DRUG; NEUTROPHIL CYTOSOL FACTOR 40K; PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CHRONIC GRANULOMATOUS DISEASE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; INNATE IMMUNITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NEUTROPHIL INFILTRATION; NEUTROPHILS; PHOSPHOPROTEINS; SIALYLTRANSFERASES;

EID: 84866545697     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103746     Document Type: Article

References (60)

1. Lambeth, J. D. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4: 181-189. (Pubitemid 38339084)
2. de Oliveira-Junior, E. B., J. Bustamante, P. E. Newburger, and A. Condino-Neto. 2011. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand. J. Immunol. 73: 420-427.
3. Dinauer, M. C. 2005. Chronic granulomatous disease and other disorders of phagocyte function. Hematology (Am. Soc. Hematol. Educ. Program) 2005: 89-95.
4. Marciano, B. E., S. D. Rosenzweig, D. E. Kleiner, V. L. Anderson, D. N. Darnell, S. Anaya-O'Brien, D. M. Hilligoss, H. L. Malech, J. I. Gallin, and S. M. Holland. 2004. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114: 462-468. (Pubitemid 39006676)
5. Rahman, F. Z., D. J. Marks, B. H. Hayee, A. M. Smith, S. L. Bloom, and A. W. Segal. 2008. Phagocyte dysfunction and inflammatory bowel disease. Inflamm. Bowel Dis. 14: 1443-1452.
6. Curran, F. T., R. N. Allan, and M. R. Keighley. 1991. Superoxide production by Crohn's disease neutrophils. Gut 32: 399-402.
7. Gionchetti, P., M. Campieri, C. Guarnieri, A. Belluzzi, C. Brignola, E. Bertinelli, M. Ferretti, M. Miglioli, and L. Barbara. 1994. Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission. Dig. Dis. Sci. 39: 550-554. (Pubitemid 24137342)
8. Hayee, B., F. Z. Rahman, J. Tempero, S. McCartney, S. L. Bloom, A. W. Segal, and A. M. Smith. 2011. The neutrophil respiratory burst and bacterial digestion in Crohn's disease. Dig. Dis. Sci. 56: 1482-1488.
9. Muise, A. M., W. Xu, C. H. Guo, T. D. Walters, V. M. Wolters, R. Fattouh, G. Y. Lam, P. Hu, R. Murchie, M. Sherlock, et al. 2012. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 61: 1028-1035.
10. Rioux, J. D., R. J. Xavier, K. D. Taylor, M. S. Silverberg, P. Goyette, A. Huett, T. Green, P. Kuballa, M. M. Barmada, L. W. Datta, et al. 2007. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39: 596-604. (Pubitemid 46676115)
11. Roberts, R. L., J. E. Hollis-Moffatt, R. B. Gearry, M. A. Kennedy, M. L. Barclay, and T. R. Merriman. 2008. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun. 9: 561-565.
12. Eglinton, T.W., R. Roberts, J. Pearson,M. Barclay, T. R. Merriman, F. A. Frizelle, and R. B. Gearry. 2012. Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort. Am. J. Gastroenterol. 107: 589-596.
13. Franke, A., D. P. McGovern, J. C. Barrett, K. Wang, G. L. Radford-Smith, T. Ahmad, C. W. Lees, T. Balschun, J. Lee, R. Roberts, et al. 2010. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42: 1118-1125.
14. Somasundaram, R., J. J. Deuring, C. J. van der Woude, M. P. Peppelenbosch, and G. M. Fuhler. 2012. Linking risk conferring mutations in NCF4 to functional consequences in Crohn's disease. Gut 61: 1097-, author reply 1097-1098.
15. phox contributes to the development of experimental inflammatory bowel disease. Immunol. Cell Biol. 89: 853-860.
16. Krieglstein, C. F., W. H. Cerwinka, F. S. Laroux, J. W. Salter, J. M. Russell, G. Schuermann, M. B. Grisham, C. R. Ross, and D. N. Granger. 2001. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J. Exp. Med. 194: 1207-1218. (Pubitemid 33055040)
17. Mori, M., K. Y. Stokes, T. Vowinkel, N. Watanabe, J. W. Elrod, N. R. Harris, D. J. Lefer, T. Hibi, and D. N. Granger. 2005. Colonic blood flow responses in experimental colitis: time course and underlying mechanisms. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G1024-G1029. (Pubitemid 41740606)
18. Fang, K., M. Bruce, C. B. Pattillo, S. Zhang, R. Stone, II, J. Clifford, and C. G. Kevil. 2011. Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. Physiol. Genomics 43: 43-56.
19. Kobayashi, S. D., J. M. Voyich, K. R. Braughton, A. R. Whitney, W. M. Nauseef, H. L.Malech, and F. R. DeLeo. 2004. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J. Immunol. 172: 636-643. (Pubitemid 38020522)
20. phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J. Exp. Med. 203: 1927-1937.
21. Cooper, H. S., S. N. Murthy, R. S. Shah, and D. J. Sedergran. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69: 238-249.
22. Murthy, S. N., H. S. Cooper, H. Shim, R. S. Shah, S. A. Ibrahim, and D. J. Sedergran. 1993. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38: 1722-1734. (Pubitemid 23271431)
23. Uhlig, H. H., B. S. McKenzie, S. Hue, C. Thompson, B. Joyce-Shaikh, R. Stepankova, N. Robinson, S. Buonocore, H. Tlaskalova-Hogenova, D. J. Cua, and F. Powrie. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25: 309-318.
24. Manocha, M., S. Rietdijk, A. Laouar, G. Liao, A. Bhan, J. Borst, C. Terhorst, and N. Manjunath. 2009. Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J. Immunol. 183: 270-276.
25. Krieglstein, C. F., C. Anthoni, W. H. Cerwinka, K. Y. Stokes, J. Russell, M. B. Grisham, and D. N. Granger. 2007. Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. Am. J. Pathol. 170: 490-496. (Pubitemid 47339386)
26. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔC(T) method. Methods 25: 402-408. (Pubitemid 34164012)
27. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3: 1101-1108. (Pubitemid 351818697)
28. Sidhu, M., C. A. Cotoner, B. Guleng, S. Arihiro, S. Chang, K. W. Duncan, A. M. Ajami, M. Chau, and H. C. Reinecker. 2011. Small molecule tyrosine kinase inhibitors for the treatment of intestinal inflammation. Inflamm. Bowel Dis. 17: 2416-2426.
29. Kobayashi, S. D., J. M. Voyich, C. L. Buhl, R. M. Stahl, and F. R. DeLeo. 2002. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc. Natl. Acad. Sci. USA 99: 6901-6906. (Pubitemid 34526230)
30. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102: 15545-15550. (Pubitemid 41528093)
31. Benita, Y., Z. Cao, C. Giallourakis, C. Li, A. Gardet, and R. J. Xavier. 2010. Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood 115: 5376-5384.
32. Morteau, O., I. Castagliuolo, A. Mykoniatis, J. Zacks, M. Wlk, B. Lu, C. Pothoulakis, N. P. Gerard, and C. Gerard. 2002. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice. Gastroenterology 122: 725-733. (Pubitemid 34173824)
33. Borregaard, N. 2010. Neutrophils, from marrow to microbes. Immunity 33: 657-670.
34. Naito, Y., T. Takagi, and T. Yoshikawa. 2007. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J. Gastroenterol. 42: 787-798. (Pubitemid 47617456)
35. Calder, P. C. 2007. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 77: 327-335. (Pubitemid 350198856)
36. Kominsky, D. J., E. L. Campbell, and S. P. Colgan. 2010. Metabolic shifts in immunity and inflammation. J. Immunol. 184: 4062-4068.
37. McGuckin, M. A., S. K. Lindén, P. Sutton, and T. H. Florin. 2011. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9: 265-278.
38. Norling, L. V., and C. N. Serhan. 2010. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J. Intern. Med. 268: 15-24.
39. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
40. Ajuebor, M. N., C. M. Hogaboam, S. L. Kunkel, A. E. Proudfoot, and J. L. Wallace. 2001. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J. Immunol. 166: 552-558. (Pubitemid 32038476)
41. Groux-Degroote, S., M. A. Krzewinski-Recchi, A. Cazet, A. Vincent, S. Lehoux, J. J. Lafitte, I. Van Seuningen, and P. Delannoy. 2008. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. Biochem. J. 410: 213-223. (Pubitemid 351300341)
42. Fischer, A. J., K. L. Goss, T. E. Scheetz, C. L. Wohlford-Lenane, J. M. Snyder, and P. B. McCray, Jr. 2009. Differential gene expression in human conducting airway surface epithelia and submucosal glands. Am. J. Respir. Cell Mol. Biol. 40: 189-199.
43. Nozaki, K., M. Ogawa, J. A. Williams, B. J. Lafleur, V. Ng, R. I. Drapkin, J. C. Mills, S. F. Konieczny, S. Nomura, and J. R. Goldenring. 2008. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology 134: 511-522. (Pubitemid 351173056)
44. Kraaij, M. D., N. D. Savage, S. W. van der Kooij, K. Koekkoek, J. Wang, J. M. van den Berg, T. H. Ottenhoff, T. W. Kuijpers, R. Holmdahl, C. van Kooten, and K. A. Gelderman. 2010. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc. Natl. Acad. Sci. USA 107: 17686-17691.
45. Tse, H. M., T. C. Thayer, C. Steele, C. M. Cuda, L. Morel, J. D. Piganelli, and C. E. Mathews. 2010. NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. J. Immunol. 185: 5247-5258.
46. Shea-Donohue, T., K. Thomas, M. J. Cody, L. J. Aiping Zhao, K. M. Detolla, M. Kopydlowski, S. A. Fukata, Lira, and S. N. Vogel. 2008. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-α), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun 14: 117-124.
47. Natsui, M., K. Kawasaki, H. Takizawa, S. I. Hayashi, Y. Matsuda, K. Sugimura, K. Seki, R. Narisawa, F. Sendo, and H. Asakura. 1997. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J. Gastroenterol. Hepatol. 12: 801-808. (Pubitemid 28088064)
48. Qualls, J. E., A. M. Kaplan, N. van Rooijen, and D. A. Cohen. 2006. Suppression of experimental colitis by intestinal mononuclear phagocytes. J. Leukoc. Biol. 80: 802-815. (Pubitemid 44835899)
49. Ellies, L. G., M. Sperandio, G. H. Underhill, J. Yousif, M. Smith, J. J. Priatel, G. S. Kansas, K. Ley, and J. D. Marth. 2002. Sialyltransferase specificity in selectin ligand formation. Blood 100: 3618-3625. (Pubitemid 35303931)
50. Frommhold, D., A. Ludwig, M. G. Bixel, A. Zarbock, I. Babushkina, M. Weissinger, S. Cauwenberghs, L. G. Ellies, J. D. Marth, A. G. Beck-Sickinger, et al. 2008. Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J. Exp. Med. 205: 1435-1446. (Pubitemid 351831498)
51. Nasirikenari, M., B. H. Segal, J. R. Ostberg, A. Urbasic, and J. T. Lau. 2006. Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood 108: 3397-3405.
52. Carnoy, C., R. Ramphal, A. Scharfman, J. M. Lo-Guidice, N. Houdret, A. Klein, C. Galabert, G. Lamblin, and P. Roussel. 1993. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 9: 323-334.
53. Davril, M., S. Degroote, P. Humbert, C. Galabert, V. Dumur, J. J. Lafitte, G. Lamblin, and P. Roussel. 1999. The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology 9: 311-321. (Pubitemid 29099717)
54. Lamblin, G., M. Lhermitte, J. J. Lafitte, M. Filliat, P. Degand, and P. Roussel. 1977. [Comparative study of bronchial mucins isolated from the sputum of patients suffering from cystic fibrosis or other chronic bronchial diseases (author's transl.)]. Bull. Eur. Physiopathol. Respir. 13: 175-190.
55. Lo-Guidice, J. M., J. M. Wieruszeski, J. Lemoine, A. Verbert, P. Roussel, and G. Lamblin. 1994. Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis. J. Biol. Chem. 269: 18794-18813. (Pubitemid 24226190)
56. Rhim, A. D., L. I. Stoykova, A. J. Trindade, M. C. Glick, and T. F. Scanlin. 2004. Altered terminal glycosylation and the pathophysiology of CF lung disease. J. Cyst. Fibros. 3(Suppl. 2): 95-96. (Pubitemid 40045576)
57. Zhang, X., and F. L. Kiechle. 2004. Review: glycosphingolipids in health and disease. Ann. Clin. Lab. Sci. 34: 3-13. (Pubitemid 38280300)
58. Einerhand, A. W., I. B. Renes, M. K. Makkink, M. van der Sluis, H. A. Büller, and J. Dekker. 2002. Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur. J. Gastroenterol. Hepatol. 14: 757-765. (Pubitemid 34753960)
59. Allahverdian, S., A. Wang, G. K. Singhera, B. W. Wong, and D. R. Dorscheid. 2010. Sialyl Lewis X modification of the epidermal growth factor receptor regulates receptor function during airway epithelial wound repair. Clin. Exp. Allergy 40: 607-618.
60. Allahverdian, S., K. R. Wojcik, and D. R. Dorscheid. 2006. Airway epithelial wound repair: role of carbohydrate sialyl Lewisx. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L828-L836. (Pubitemid 44498496)